CEO@ The Behnke Group LLC, CEO@ Cizzle Bio Inc. USA. Performance-Driven Executive Specializing in Health Care
A Milestone in Healthcare Innovation I am proud to share an exciting update from Cizzle Biotechnology, where a significant fundraising effort has successfully raised £0.62 million. This crucial funding will accelerate the development of the CIZ1B biomarker test for early-stage lung cancer, marking a pivotal advancement in our fight against this deadly disease. Read more about this strategic milestone and its impact on our mission to enhance early cancer detection: https://buff.ly/3Wdut0J #HealthcareInnovation #LungCancerDetection #Leadership #TheBehnkeGroup